FAMHP (Belgian Medicine Agency)

Future European legislation: state of play

FAMHP updates on pending EU legislative initiatives including MDR/IVDR revision, Biotech Act, Critical Medicines Act, pharmaceutical legislation, and online health information measures.

Medium impact Medical Devices Digital Health & AI Market Access & Reimbursement Belgium medical-devicespharmaceuticalsdigital-therapeutics

European legislative initiatives such as the Biotech Act, the MDR/IVDR revision, the Critical Medicines Act, the new European pharmaceutical legislation and measures relating to online health information will have a significant impact on all stakeholders. The FAMHP provides an update on the current situation.

Read the official source ↗

Published by FAMHP (Belgian Medicine Agency). HealthSignal links to the original document; the summary above is extracted from the source text.